Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:13 PM
Ignite Modification Date:
2025-12-24 @ 10:13 PM
NCT ID:
NCT03831035
Eligibility Criteria:
Inclusion Criteria:
* Infant aged under 12 months , hospitalized in the ICU.
* Infant with multiple congenital malformations or neurological symptoms for which a genetic origin is suspected but undiagnosed genetically.
* Infant for whom both biological parents have given consent for the study, genetic analysis for themselves anf their child.
* Infant and parents registered in the French National health service
Exclusion Criteria:
* Absence of one or both parental sample.
* Precise genetic diagnosis made pre- or post-natally with chromosomal (I.e : Down syndrome), Sanger (i.e : infantile spinal amyotrophia) methylation (i.e : Prader-Willi syndrome) or triplet amplification (I.e : neonatal Steinert myotonia) studies.
* Strong clinical evidence for a with chromosomal (I.e : Down syndrome), Sanger (i.e : infantile spinal amyotrophia) methylation (i.e : Prader-Willi syndrome) or triplet amplification (I.e : neonatal Steinert myotonia) studies.
* Impossibility for one or both parents to give his or her consent
Healthy Volunteers:
True
Sex:
ALL
Minimum Age:
1 Day
Maximum Age:
12 Months
Study:
NCT03831035
Study Brief:
Protocol Section:
NCT03831035